The clinical utility of bone marker measurements in osteoporosis. - Wikidata - wikimedia - TriplyDB

The clinical utility of bone marker measurements in osteoporosis.

The clinical utility of bone marker measurements in osteoporosis.

http://www.wikidata.org/entity/Q37153332

about

Natural Products from Chinese Medicines with Potential Benefits to Bone Health Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women's health practice Bone turnover markers: Emerging tool in the management of osteoporosis Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy Bone-Protective Effects of Dried Plum in Postmenopausal Women: Efficacy and Possible Mechanisms.Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy Expressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosis The biological effects of tocotrienol on bone: a review on evidence from rodent models.Bone remodeling markers and bone metastases: From cancer research to clinical implications Risk factors of adjacent vertebral collapse after percutaneous vertebroplasty for osteoporotic vertebral fracture in postmenopausal women Overview of research studies on osteoporosis in menopausal women since the last decade.Decreased Bone Mineral Density at the Femoral Neck and Lumbar Spine in South Indian Patients with Type 2 Diabetes.Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OA Short-Term Isoflavone Intervention in the Treatment of Severe Vasomotor Symptoms after Surgical Menopause: A Case Report and Literature Review Changes in the plasma levels of several bone markers in newborn calves during the first two days of life Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury.Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing's syndrome.The association between bone turnover markers and kyphosis in community-dwelling older adults.Circulating microRNAs Correlated with Bone Loss Induced by 45 Days of Bed Rest.Effect of vitamin D3-supplementation on bone markers (serum P1NP and CTX): A randomized, double blinded, placebo controlled trial among healthy immigrants living in Norway Bone markers and osteoporosis therapy.Is calcaneal quantitative ultrasound useful as a prescreen stratification tool for osteoporosis?Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.The Effect of Taichi Practice on Attenuating Bone Mineral Density Loss: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.In Situ Sensor Advancements for Osteoporosis Prevention, Diagnosis, and Treatment.Pediatric Osteoporosis: Diagnosis and Treatment Considerations.Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.Bone turnover markers in sheep and goat: A review of the scientific literature.Circulating markers of bone turnover.Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications Review article: effects of type 2 diabetes therapies on bone metabolism.The effects of short-term jump training on bone metabolism in females using oral contraceptives.Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.Low Doses of Simvastatin Potentiate the Effect of Sodium Alendronate in Inhibiting Bone Resorption and Restore Microstructural and Mechanical Bone Properties in Glucocorticoid-Induced Osteoporosis.Bone Mineral Density is Lower in Patients with Severe Knee Osteoarthritis and Attrition.Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial.Dietary Patterns and Fractures Risk in the Elderly.

P2860

Q26765485-4BFEAA71-C431-46BB-9E64-09EB4FFBBCCA Q28066185-0EB935CB-E8A0-48C9-BCA1-B2B29433264A Q28074551-EC4F3BE6-A98C-43E5-9635-D082AA6362DA Q28546638-A8090D96-AA84-42F2-9B99-C395C3530613 Q33749496-29118889-2F86-4283-8196-B7989431220D Q34317162-3978DC38-C84A-45D5-88BD-8447DE22407C Q35277349-B079D57F-7D27-4999-82D7-5691B9941966 Q35410229-C0929FDB-D2BB-4CDE-992E-AC5916A33100 Q35531006-2BCDB820-45A5-4BBA-B09E-93C115A28105 Q35891879-208E24C3-45BA-4B59-9CDF-ADE1814F85DD Q36159390-711F1AA0-A92A-429F-91B5-320DFD5883EC Q36163043-F5A2FAD8-F5B4-4A6D-B627-470BEAF726E6 Q36255352-246A67EE-161B-41D4-8CC1-77C147731624 Q36271933-16562D35-76D7-4C00-9DA8-03487875DEE6 Q36669920-980BE891-D779-42D7-ADAA-9515DF1BC038 Q36885350-19F9708E-0E9C-42C9-B653-3A32FD42FB26 Q37007565-A277AE07-68F4-41DC-9A76-DFA4A5286A65 Q37051639-637812A9-1E03-4F08-82B8-C7FD646EAD31 Q37639778-96AACE7C-FD08-4747-803C-A95B903F275E Q37720395-2DFC583B-AC23-487A-A539-32C973FE6DAD Q38244170-251C01AC-E966-4278-8B8C-1FC77D73C0FE Q38337303-0E798AF0-4647-41FA-B757-42AE149FA30A Q38426359-65745A2A-BCEC-4C40-93A2-B1A4370BDB22 Q38503214-5F9ACAE4-85DD-47F0-9407-CEAD8926FDCC Q38598056-788D2CED-6BAF-49F7-8849-169A57CC6B03 Q38787494-ADB08A97-3727-4B64-AE33-A57BC78EDDED Q38798360-A8C97EE0-EB8C-4F4B-887B-39BE94AB7477 Q38921958-50FC1F09-6A8C-438D-8195-4A9ED62B2042 Q39022309-01215067-DDD5-4DB9-9C36-F7A96898927C Q39168502-ADCBA8C7-0657-4AC4-8A43-AF28AA9D01BD Q39304775-2E959C32-C0AB-4231-BE10-7193CDA24A62 Q40679886-B06E9500-6C2C-47FC-BD63-34F932EC90C4 Q42363966-4B769F50-9C08-4EF5-BDE2-FA88A64EC40C Q46026235-E158EC7F-83CE-48C8-9816-787A962853B6 Q47116443-01E5BF23-1A16-4FD9-9EFB-8DC74DAD8012 Q48029073-1F6C22AA-39DB-40AF-9D96-4DB67DFB9EB1 Q48055309-D8D6284D-CEB4-4A6C-88F6-6EF46E293BE3 Q48235237-14B09C28-513D-4085-A562-0820360FE9EA Q48332923-56AA4A5F-2C5D-4A4A-8E93-374D55681D3E Q49631462-0F873BC8-7DD4-4307-9666-FE6084CFD085

P2860

The clinical utility of bone marker measurements in osteoporosis.

http://www.wikidata.org/entity/Q37153332

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The clinical utility of bone marker measurements in osteoporosis.

@en

The clinical utility of bone marker measurements in osteoporosis.

@nl

type

label

The clinical utility of bone marker measurements in osteoporosis.

@en

The clinical utility of bone marker measurements in osteoporosis.

@nl

prefLabel

The clinical utility of bone marker measurements in osteoporosis.

@en

The clinical utility of bone marker measurements in osteoporosis.

@nl

P1433

Q37153332-DBF83E27-4FC1-4A0F-A6BB-872896ACCCBB

P1476

Q37153332-07F88750-4BFD-4BA0-B618-D063F1826BA1

P2093

Q37153332-1A41C440-BDF7-45F9-90B1-1FA87C97BE10

Q37153332-783CDD04-67D2-455E-811A-A4FD7308D93E

Q37153332-A81C4F63-3B19-424F-952E-69C6E95BA2F2

Q37153332-AEDBD50A-D5A2-462E-A48C-1C5D8FB13BC5

Q37153332-CE0A5EE1-4194-4461-8197-85F252499E0E

P275

Q37153332-AAC2D62F-D6DC-4AD0-8B2B-79BA658B2974

P2860

Q37153332-0281DF90-0DA6-4AD4-A6ED-79DC67B3AE00

Q37153332-06D53DA2-C880-4163-B13C-F66FE02BCC24

Q37153332-083FE838-19A1-44A4-85A6-77742174BCE8

Q37153332-0AB8418F-97DD-4618-872E-F895D9C48F98

Q37153332-0BDC5D33-ECF5-49CD-8D0D-64E986B31D92

Q37153332-0FD740D6-5207-4009-8D96-4BFED3C1A2CD

Q37153332-122D7303-0E47-49BD-8DB3-5CA70DC0E04E

Q37153332-174EDF6F-DF0A-4FF5-B79B-A123699C0DC9

Q37153332-1804496D-38F3-44A6-AD37-02987C97DD9B

Q37153332-18D4B88C-698A-4C5D-838B-0E266A9DAC98

P2888

Q37153332-580942D7-432D-48C5-80E4-D25BEC41CE84

P304

Q37153332-EA40B805-C872-414A-AC88-F7596909D14A

P31

Q37153332-037E1D97-CE82-41E7-B2BC-8C3652CA8A23

Q37153332-189DFA9E-A822-4732-B836-B090FD111F0E

P356

Q37153332-4DD77548-B305-4403-8308-D0CFC43178B3

P478

Q37153332-7387C445-3529-4D25-B6FB-EB9D523CE38E

P5008

Q37153332-ABB983BF-535B-4313-BA40-DD1FDDF3A4BD

P577

Q37153332-DCCF04B5-FCE2-4596-A5A7-E585843084F1

P5875

Q37153332-914C1A50-8A4E-4309-87D6-6C8E1EC7FB8D

P6179

Q37153332-8C8D614F-4456-4A7E-A7DE-C1AF4E95881B

P698

Q37153332-EDA58D93-7B64-4333-A78B-C87132A8782E

P921

Q37153332-154F8818-62CF-4572-B336-22C58F805C60

Q37153332-30D93806-8501-4997-BF0C-660D5547E03E

Q37153332-E373F5AC-C976-4554-8761-1F9DEAF9AEFF

P932

Q37153332-977FDAE6-8918-44FF-AA69-033F523C1A96

P356

1479-5876-11-201

P1433

Journal of Translational Medicine

P1476

The clinical utility of bone marker measurements in osteoporosis.

@en

P2093

Gillian Wheater

http://www.w3.org/2001/XMLSchema#string

Harish K Datta

http://www.w3.org/2001/XMLSchema#string

Jacob M van Laar

http://www.w3.org/2001/XMLSchema#string

Mohsen Elshahaly

http://www.w3.org/2001/XMLSchema#string

Stephen P Tuck

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Effects of PTH on osteocyte function

The skeletal consequences of thyrotoxicosis

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges.

Laboratory reproducibility of biochemical markers of bone turnover in clinical practice.

Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy.

Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases.

Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.

P2888

1479-5876-11-201

P304

201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-11-201

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256200241

http://www.w3.org/2001/XMLSchema#string

P6179

1001368448

http://www.w3.org/2001/XMLSchema#string

P698

23984630

http://www.w3.org/2001/XMLSchema#string

P921

human musculoskeletal system

P932

3765909

http://www.w3.org/2001/XMLSchema#string